These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14769142)

  • 21. Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer.
    Wang ML; Yung WK; Royce ME; Schomer DF; Theriault RL
    Am J Clin Oncol; 2001 Aug; 24(4):421-4. PubMed ID: 11474279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced dose capecitabine is an effective and well-tolerated treatment in patients with metastatic breast cancer.
    El-Helw L; Coleman RE
    Breast; 2005 Oct; 14(5):368-74. PubMed ID: 16216738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature.
    Minisini AM; Pauletto G; Bergonzi P; Fasola G
    Breast Cancer Res Treat; 2007 Oct; 105(2):133-8. PubMed ID: 17123150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capecitabine in the routine treatment of advanced breast cancer: results from a non-interventional observational study in 876 [corrected] patients.
    Siedentopf F; Gohler T; Hesse T; Nusch A; Sulberg H
    Onkologie; 2009 Nov; 32(11):631-6. PubMed ID: 19887866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare case of non-immune hemolytic anemia in a patient with metastatic breast cancer treated with capecitabine.
    Shaaban H; Downs E; Shakouri P; Guron G
    Med Oncol; 2013 Mar; 30(1):321. PubMed ID: 23254961
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N; Misra V
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actinic keratosis and capecitabine therapy.
    Higa GM; Kovach RF; Abraham J
    J Oncol Pharm Pract; 2005 Dec; 11(4):151-3. PubMed ID: 16595067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
    Bar-Sela G; Haim N
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of local-recurring breast cancer under long term-treatment by capecitabine].
    Yoneyama K; Takeshita T; Suzuki H; Morise M; Suzuki T; Kishi S; Tsutsui A; Matsumoto A
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2623-5. PubMed ID: 22189229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term response of liver metastases of breast cancer to capecitabine--case report].
    Macková D
    Klin Onkol; 2010; 23(1):46-8. PubMed ID: 20192074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor lysis syndrome following a single dose of capecitabine.
    Kurt M; Eren OO; Engin H; Güler N
    Ann Pharmacother; 2004 May; 38(5):902. PubMed ID: 15039470
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of capecitabine therapy on the blood levels of antiepileptic drugs - report of two cases].
    Tanaka H; Jotoku H; Takasaki M; Ibayashi Y; Watanabe K; Takahashi M
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):527-30. PubMed ID: 24743375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moving forward with capecitabine: a glimpse of the future.
    Biganzoli L; Martin M; Twelves C
    Oncologist; 2002; 7 Suppl 6():29-35. PubMed ID: 12454317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent radiotherapy and capecitabine, followed by high-dose methotrexate consolidation, provided effective palliation in a patient with leptomeningeal metastases from breast cancer.
    Carmona-Bayonas A
    Ann Oncol; 2007 Jan; 18(1):199-200. PubMed ID: 16980605
    [No Abstract]   [Full Text] [Related]  

  • 36. Nursing considerations for capecitabine-based combination therapy.
    Becze E
    ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236
    [No Abstract]   [Full Text] [Related]  

  • 37. Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab.
    Platini C; Long J; Walter S
    Lancet Oncol; 2006 Sep; 7(9):778-80. PubMed ID: 16945774
    [No Abstract]   [Full Text] [Related]  

  • 38. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
    Dalmau J; Roé E; Puig L; Alomar A
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
    [No Abstract]   [Full Text] [Related]  

  • 39. Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer.
    Ershler WB
    Oncologist; 2006 Apr; 11(4):325-35. PubMed ID: 16614228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capecitabine monotherapy in metastatic colorectal cancer.
    Twelves C; Hargreaves D; Nguyen-Van-Tam J; Ng T
    Lancet Oncol; 2001 Jul; 2(7):400. PubMed ID: 11905733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.